Ming Zheng
About Ming Zheng
Ming Zheng is the Director of Quantitative Clinical Pharmacology at Bristol-Myers Squibb in New York, with over 25 years of experience in clinical pharmacology and pharmacometrics.
Current Position
Ming Zheng is currently positioned as the Director of Quantitative Clinical Pharmacology at Bristol-Myers Squibb in New York, New York, United States. In this role, Ming collaborates with cross-functional teams to optimize clinical pharmacology strategies for new drug candidates.
Previous Roles at Bristol-Myers Squibb
Ming Zheng has held multiple positions at Bristol-Myers Squibb. Initially joining as a Senior Research Investigator in Discovery DMPK from 1997 to 2008, Ming then served as Associate Director in Clinical Pharmacology and Pharmacometrics from 2008 to 2013, and later as Associate Director of Quantitative Clinical Pharmacology from 2013 to 2015.
Role at Daiichi Sankyo, Inc.
In February 2015, Ming Zheng joined Daiichi Sankyo, Inc. as Senior Director of Quantitative Clinical Pharmacology. During this time, Ming continued to leverage expertise in drug discovery, development, and clinical pharmacology.
Educational Background
Ming Zheng studied at Shanghai Medical University before pursuing further education at the University of British Columbia. Ming achieved a Doctor of Philosophy (Ph.D.) from the University of British Columbia, completing the doctoral studies between 1993 and 1997.
Industry Experience
With over 25 years of experience, Ming Zheng has a robust background in clinical pharmacology and pharmacometrics, particularly focusing on Drug Metabolism and Pharmacokinetics (DMPK). Throughout Ming's career, significant contributions have been made towards multiple successful drug approvals.